GILT Docetaxel - Non-Small Cell Lung Cancer
type: MedicalStudy
description: Open-Label, Cooperative, Randomized, Multicenter Phase III Study on the Use of Cisplatin Resistant Genotype (ERCC1 Over-Expression) in Tumor RNA to Customize Chemotherapy in Stage IV-IIIB (Malignant Pleural Effusion) Non-Small-Cell Lung Cancer Patients
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2001-06
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00174629
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Sanofi
study subject: Lung Neoplasms
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Lung Neoplasms

AI Analytics
type: Organization